Prominent Intravenous Fluid Transfer Drug Devices Market Trend for 2025: Advancements In Intravenous Fluid Transfer Devices By Enhancing Safety And Efficiency

What Are the Projected Growth and Market Size Trends for the Intravenous Fluid Transfer Drug Devices Market?
The market size for intravenous fluid transfer drug devices has seen substantial growth lately. The value is projected to increase from $7.38 billion in 2024 to $7.85 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.4%. This upward trend during the historical period can be attributed to a rise in demand for efficient medical equipment, expansion of healthcare facilities, escalation in the number of surgeries necessitating IV support, policy shifts, growth in healthcare infrastructure, and the development of new drugs that require accurate administration.

The market for intravenous fluid transfer drug devices is projected to experience significant expansion in the upcoming years, with an anticipated size of $9.96 billion by 2029 and a compound annual growth rate (CAGR) of 6.1%. Factors such as increasing need for mobile devices, enhanced expenditures on high-tech medical devices, surging demand for cost-effective healthcare options, and the development of treatment environments beyond hospitals are predominantly contributing to the growth in this forecast period. Crucial trends during this period encompass integration with smart technologies, adoption of automated IV fluid transfer systems, improvements in safety measures to minimize drug mistakes, and the acceptance of devices that can be remotely monitored.

What Is Driving the Growth Trajectory of the Intravenous Fluid Transfer Drug Devices Market?
The anticipated growth in the intravenous fluid transfer drug device market is expected to surge due to increasing hospitalization rates. This increase can be attributed to several factors such as an aging populace, expanding prevalent of chronic diseases, advancements in diagnostic procedures, and a broader scope of healthcare access. Lifestyle-related diseases and technological progression within the medical field also largely contribute. Intravenous fluid transfer systems are crucial to ensure accurate and regulated delivery of fluids and drugs straight into the bloodstream of hospital patients. For instance, the American Hospital Association (AHA), a US-focused trade organization representing hospital institutions and healthcare networks, reported in May 2023, that the sum of admissions in all hospitals throughout the United States was 34,011,386, showing a rise from 33,356,853 admissions in 2022. Accordingly, the surge in hospitalization rates will contribute to the expansion of the intravenous fluid transfer drug device market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Which Leading Companies Are Shaping the Growth of the Intravenous Fluid Transfer Drug Devices Market?
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG

What Are the Major Trends Shaping the Intravenous Fluid Transfer Drug Devices Market?
Leading businesses in the intravenous fluid transfer drug device market are innovating to produce modular and all-inclusive infusion systems. These systems feature auto-identification to augment precision, elevate patient safety, and simplify the management of fluids and medications. Auto-identification in these infusion systems instantaneously validates and maps medications to the correct patient leveraging barcode scanning or RFID technology. For instance, Becton, Dickinson, and Company, an American medical device firm, gained FDA 510(k) clearance in July 2023 for its refreshed BD Alaris Infusion System. The revamped BD Alaris Infusion System contains updated hardware for its Point-of-Care Unit (PCU), comprising large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Moreover, the system launches an improved software iteration with enhanced cybersecurity and interoperability characteristics that enable effortless integration with commonly used electronic medical record (EMR) systems, facilitating smart and connected healthcare.

What Are the Key Segments of the Intravenous Fluid Transfer Drug Devices Market?
The intravenous fluid transfer drug devicesmarket covered in this report is segmented -

1) By Type: Infusion Bags, Infusion Devices, Other Types
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Region Dominates the Intravenous Fluid Transfer Drug Devices Market?
North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Intravenous Fluid Transfer Drug Devices Global Market Report?

- Market Size Analysis: Analyze the Intravenous Fluid Transfer Drug Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Intravenous Fluid Transfer Drug Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Intravenous Fluid Transfer Drug Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Intravenous Fluid Transfer Drug Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19535

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.